These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29234909)

  • 21. Cholesterol and chloroquine.
    Borba EF
    Rev Bras Reumatol; 2011 Dec; 51(6):673. PubMed ID: 22124601
    [No Abstract]   [Full Text] [Related]  

  • 22. New therapies for systemic lupus erythematosus: cellular targets.
    Looney RJ; Anolik J; Sanz I
    Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.
    Oliveira AC; Mota LM; Santos-Neto LL; Simões M; Martins-Filho OA; Tauil PL
    Arthritis Rheumatol; 2015 Feb; 67(2):582-3. PubMed ID: 25418753
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic lupus erythematosus.
    Ginzler EM; Dooley MA
    Rheum Dis Clin North Am; 2014 Aug; 40(3):xiii-xiv. PubMed ID: 25034164
    [No Abstract]   [Full Text] [Related]  

  • 25. Newer therapeutic approaches for systemic lupus erythematosus.
    Ginzler EM; Dvorkina O
    Rheum Dis Clin North Am; 2005 May; 31(2):315-28. PubMed ID: 15922148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
    Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
    Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 28. New therapies in systemic lupus erythematosus--trials, troubles and tribulations--working towards a solution: part 2--the politically incorrect version.
    Wallace DJ
    Lupus; 2009 Feb; 18(2):101-3. PubMed ID: 19151109
    [No Abstract]   [Full Text] [Related]  

  • 29. Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus.
    Sabbagh M
    Rev Rhum Engl Ed; 1997 Jan; 64(1):65. PubMed ID: 9051865
    [No Abstract]   [Full Text] [Related]  

  • 30. [Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].
    Bader-Meunier B
    Arch Pediatr; 2010 Jun; 17(6):632-3. PubMed ID: 20654815
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.
    Huggins JL; Brunner HI
    J Pediatr; 2006 May; 148(5):571-3. PubMed ID: 16737861
    [No Abstract]   [Full Text] [Related]  

  • 32. [Belimumab--the biological treatment for systemic lupus erythematosus--first in 50 years].
    Vadasz Z; Toubi E
    Harefuah; 2011 Dec; 150(12):880-3. PubMed ID: 22352276
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
    Torrente-Segarra V; Lisbona-Pérez M; Rotes-Sala D; Castro-Oreiro S; Carbonell-Abelló J
    Lupus; 2009 Mar; 18(3):270-2. PubMed ID: 19213868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF inhibition in SLE: where do we stand?
    Aringer M; Smolen JS
    Lupus; 2009 Jan; 18(1):5-8. PubMed ID: 19074162
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of systemic lupus erythematosus complicated with multicentric reticulohistiocytosis (MRH): successful treatment of MRH and lupus nephritis with cyclosporin A.
    Saito K; Fujii K; Awazu Y; Nakayamada S; Fujii Y; Ota T; Tanaka Y
    Lupus; 2001; 10(2):129-32. PubMed ID: 11237126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The management of systemic lupus erythematosus with biological therapies].
    Malaise O; von Frenckell C; André B; Malaise MG
    Rev Med Suisse; 2013 Aug; 9(395):1507-11. PubMed ID: 24024419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus.
    Marks SD; Tullus K
    Pediatr Nephrol; 2006 Apr; 21(4):598-9. PubMed ID: 16508774
    [No Abstract]   [Full Text] [Related]  

  • 38. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus.
    Ikeda F; Watanabe S; Aizawa-Yashiro T; Tsuruga K; Ito E; Tanaka H
    Lupus; 2013 Dec; 22(14):1541-3. PubMed ID: 23966305
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 40. Biologics in systemic lupus erythematosus: current options and future perspectives.
    Md Yusof MY; Vital EM; Emery P
    Br J Hosp Med (Lond); 2014 Aug; 75(8):440, 442-7. PubMed ID: 25111095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.